Targetcountry/Date | Target | Deal_value (тыс. $) | Patents (ед.) | Country | BigPharma | Intangible assets (тыс. $) | GDP (тыс. $) |
US 2010 | AbraxisBioScience Inc. | 2905158.00 | 3 | 0 | 0 | 385994.00 | 48.294 |
IS 2012 | Actavis Group hf | 5847193.35 | 17 | 1 | 0 | 3321900.00 | 39.544 |
US 2011 | AdvancedBioHealingInc. | 750000.00 | 13 | 1 | 0 | 708.00 | 49.797 |
CH 2010 | Alcon | 28300000.00 | 13 | 0 | 1 | 943000.00 | 43.207 |
US 2008 | Alpharma | 1400000.00 | 6 | 0 | 1 | 478621.00 | 48.308 |
US 2011 | AmericanMedicalSystemsHoldings | 2900000.00 | 15 | 0 | 0 | 792467.00 | 49.797 |
FR 2008 | Aventis | 65500000.00 | 54 | 0 | 1 | 1218570.00 | 29.329 |
GB2009 | Axis-Shield | 365000.00 | 12 | 1 | 0 | 44993.20 | 34.617 |
US 2008 | Barrpharmaceuticals | 8960000.00 | 25 | 1 | 1 | 1769377.00 | 48.308 |
US 2011 | BaxoCorp. | 325000.00 | 5 | 1 | 0 | 51510.00 | 49.797 |
US 2011 | CaracoPharmaceuticalLaboratoriesLtd | 210942.15 | 8 | 1 | 0 | 1286.00 | 49.797 |
DE 2014 | Celesio | 8300000.00 | 20 | 1 | 0 | 295320.00 | 40.007 |
US 2011 | CephalonInc | 6800000.00 | 19 | 1 | 0 | 2034458.00 | 49.797 |
AU 2011 | ChemGenexPharmaceuticalsLtd. | 231000.00 | 16 | 0 | 0 | 113781.00 | 39.329 |
NL 2011 | Crucell N. V. | 2300000.00 | 22 | 1 | 1 | 175975.24 | 42.183 |
US 2011 | Dionex | 2064389.00 | 6 | 0 | 0 | 48872.00 | 49.797 |
IE 2013 | ElanCorp. | 8600000.00 | 10 | 0 | 1 | 76000.00 | 39.547 |
ZA 2011 | ElanDrugTechnologiesInc. | 960000.00 | 14 | 0 | 0 | 366700.00 | 10.725 |
US 2010 | EV3 (EVVV) | 2600000.00 | 10 | 0 | 0 | 621774.00 | 48.294 |
US 2011 | GenzymeCorp. | 20100000.00 | 8 | 0 | 1 | 3161797.00 | 49.797 |
US 2013 | HealthManagementAssociates | 3900000.00 | 8 | 0 | 1 | 1124337.00 | 53.101 |
US 2011 | InspirePharmaceuticalsInc. | 430000.00 | 7 | 0 | 1 | 13154.00 | 49.797 |
US 2010 | InVentivHealthInc. | 1100000.00 | 3 | 0 | 0 | 480811.00 | 48.294 |
FR 2011 | Ipsogen S. A. | 91290.03 | 8 | 1 | 0 | 2611939.98 | 34.871 |
US 2011 | KingPharmaceuticals | 3600000.00 | 4 | 0 | 1 | 1261752.00 | 49.797 |
US 2014 | LifeTechnologies | 15100000.00 | 17 | 0 | 1 | 6029215.00 | 55.614 |
US 2011 | MartekBiosciencesCorporation | 1087000.00 | 10 | 1 | 0 | 94223.00 | 49.797 |
IN 2009 | Matrixlaboratories | 736000.00 | 12 | 1 | 0 | 147329.00 | 3.141 |
US 2012 | MedcoHealthSolutions | 29100000.00 | 11 | 0 | 1 | 9349300.00 | 51.709 |
US 2012 | Medicispharmaceuticalcorporation | 2600000.00 | 12 | 1 | 0 | 705119.00 | 51.709 |
US 2010 | Millipore | 7200000.00 | 10 | 0 | 1 | 1908105.00 | 48.294 |
US 2010 | NBTY | 3800000.00 | 10 | 0 | 0 | 533620.00 | 48.294 |
Данные для регрессионного анализа (продолжение) | |||||||
Targetcountry/Date | Target | Deal_value (тыс. $) | Patents (ед.) | Country | Big Pharma | Intangible assets (тыс. $) | GDP (тыс. $) |
US 2009 | NovenPharmaceuticalsInc. | 434279.10 | 11 | 1 | 0 | 50915.00 | 46.907 |
US 2013 | OnyxPharma | 9700000.00 | 15 | 0 | 1 | 366175.00 | 53.101 |
US 2010 | OSI Pharm. | 4000000.00 | 21 | 1 | 1 | 481873.00 | 48.294 |
US 2010 | OSTEOTECH, INC. | 123000.00 | 13 | 0 | 0 | 16861.00 | 48.294 |
US 2012 | ParPharmaceuticalInc. | 1900000.00 | 16 | 0 | 0 | 595101.00 | 51.709 |
IN 2010 | Piramalhealthcare | 3700000.00 | 5 | 0 | 0 | 214636.80 | 3.457 |
US 2009 | Schering-ploughCorp. | 41100000.00 | 12 | 0 | 1 | 5165650.00 | 46.907 |
US 2009 | SEPRACOR INC. | 2600000.00 | 17 | 0 | 0 | 174834.00 | 46907 |
US 2010 | Solvaypharmaceuticals | 8960000.00 | 42 | 1 | 1 | 1732558.00 | 48.294 |
GB 2010 | SSL International LTD | 3900000.00 | 3 | 1 | 0 | 2420836.00 | 35.349 |
JP 2010 | SSP | 913000.00 | 6 | 0 | 0 | 474667.75 | 33.981 |
CH 2012 | Synthes | 21300000.00 | 36 | 1 | 0 | 3373694.00 | 45.128 |
US 2011 | TalecrisBiotherapeuticsHoldingsCorp. | 3400000.00 | 7 | 1 | 1 | 183740.00 | 49.797 |
US 2013 | TenetHealthcare | 4300000.00 | 10 | 0 | 0 | 1566000.00 | 53.101 |
US 2010 | US Oncology | 2160000.00 | 20 | 0 | 0 | 631911.00 | 48.294 |
US 2010 | Valeant | 3237551.00 | 15 | 1 | 0 | 665696.00 | 48.294 |
IN 2013 | VioPharma | 4200000.00 | 11 | 0 | 0 | 142407.00 | 3.900 |
CN 2010 | Wuxi | 1600000.00 | 5 | 0 | 1 | 455830.00 | 7.487 |
RO 2009 | Zentiva | 2400000.00 | 22 | 1 | 0 | 758621.35 | 11.834 |
US 2013 | ZoetisInc. | 12375000.00 | 13 | 0 | 1 | 1853000.00 | 53.101 |
ПРИЛОЖЕНИЕ 2
Консолидированный балансовый отчет DionexCorporation за 2010 г. (тыс. $)
ПРИЛОЖЕНИЕ 3
Консолидированный балансовый отчет ThermoFisherScientificIncorporation за 2010 г. (млн. $)
ПРИЛОЖЕНИЕ 4
Консолидированный балансовый отчет ThermoFisherScientificIncorporation за 2012 г. (млн. $)
1European Federation of Pharmaceutical Industries Associations – ЕвропейскаяФедерацияфармацевтическойпромышленности
|
Из за большого объема этот материал размещен на нескольких страницах:
1 2 3 4 5 6 7 8 9 10 11 12 |
